tryptophan has been researched along with Huntington Disease in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (30.30) | 18.7374 |
| 1990's | 7 (21.21) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S | 1 |
| Tanaka, M; Toldi, J; Vécsei, L | 1 |
| Breda, C; Giorgini, F; Sathyasaikumar, KV; Schwarcz, R | 1 |
| Adomat, H; Budac, DP; Leavitt, BR; Lu, G; Mazarei, G; Möller, T; Tomlinson Guns, ES | 1 |
| Leavitt, BR; Mazarei, G | 1 |
| Costantino, G | 1 |
| Guidetti, P; Muchowski, PJ; Sathyasaikumar, KV; Schwarcz, R | 1 |
| Amori, L; Guidetti, P; Muchowski, PJ; Sathyasaikumar, KV; Schwarcz, R; Stachowski, EK | 1 |
| Breda, C; Campesan, S; Giorgini, F; Green, EW; Kyriacou, CP; Muchowski, PJ; Sathyasaikumar, KV; Schwarcz, R | 1 |
| Tan, L; Yu, JT | 1 |
| Bader, M; Bauer, A; Bauer, I; Grasshoff, U; Holzmann, C; Jones, L; Kask, A; Kobbe, P; Krotova, J; Landwehrmeyer, B; Li, XJ; Lindenberg, KS; Nguyen, HP; Pabst, R; Paul, M; Rathke-Hartlieb, S; Riess, O; Schmidt, T; Schmitt, I; Schulz, JB; Stiller, D; Vaarmann, A; Vieira-Saecker, AM; von Hörsten, S; Walther, T | 1 |
| Clark, CJ; Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW | 1 |
| Christofides, J; Darlington, LG; Egerton, M; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N | 1 |
| Bridel, M; Christofides, J; Darlington, LG; Egerton, M; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N | 1 |
| Kato, Y; Kurita, J; Miyakawa, T; Tanokura, M | 1 |
| Perez-De La Cruz, V; Santamaria, A | 1 |
| Belendiuk, GW; Belendiuk, K; Freedman, DX | 1 |
| Pearson, SJ; Reynolds, GP | 2 |
| Pascoe, M | 1 |
| Benitez, J; Díaz Neira, W; García de Yebenes, J; García Ruiz, PJ; Gimenez Roldan, S; Mena, MA; Sanchez Bernardos, V | 1 |
| Fuchs, D; Jellinger, K; Laccone, F; Leblhuber, F; Tilz, GP; Walli, J; Widner, B | 1 |
| Demel, U; Fuchs, D; Leblhuber, F; Tilz, GP; Walli, J; Widner, B | 1 |
| Curzon, G; Kantamaneni, BD | 1 |
| Bird, ED; Phillipson, OT | 1 |
| Growdon, JH; Wurtman, RJ | 1 |
| Beal, MF; Bird, ED; Matson, WR; Milbury, P; Ogawa, T; Ryan, EA; Storey, E | 1 |
| Beal, MF; Bird, ED; Gamache, PH; Matson, WR; Swartz, KJ | 1 |
| Oepen, H; Oepen, I | 1 |
| Ottosson, JO; Rapp, W | 1 |
| Horne, DJ; McLeod, WR | 1 |
| Davidson, D; Magill, BE; Murray, LG; Pullar, IA; Wilson, H; Yates, CM | 1 |
| Chase, TN; Murphy, DL; Pérez-Cruet, J | 1 |
9 review(s) available for tryptophan and Huntington Disease
| Article | Year |
|---|---|
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan | 2022 |
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
Topics: Alzheimer Disease; Anti-Inflammatory Agents; Biomarkers; Cytokines; Humans; Huntington Disease; Inflammation; Kynurenine; Neurodegenerative Diseases; Parkinson Disease; Reactive Oxygen Species; Tryptophan | 2020 |
Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
Topics: Alzheimer Disease; Animals; Humans; Huntington Disease; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Parkinson Disease; Signal Transduction; Tryptophan | 2015 |
New promises for manipulation of kynurenine pathway in cancer and neurological diseases.
Topics: Animals; Drug Delivery Systems; Drug Discovery; Humans; Huntington Disease; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Neoplasms; Schizophrenia; Tryptophan | 2009 |
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.
Topics: Animals; Disease Models, Animal; Dopamine; Humans; Huntington Disease; Kynurenine; Mice; Mutation; Peptides; Quinolinic Acid; Rats; Receptors, Glutamate; Serotonin Plasma Membrane Transport Proteins; Tryptophan | 2010 |
The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Topics: Aging; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Enzyme Inhibitors; Humans; Huntington Disease; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenic Acid; Kynurenine; Microglia; Molecular Targeted Therapy; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Quinolinic Acid; Receptors, G-Protein-Coupled; Receptors, N-Methyl-D-Aspartate; Tryptophan | 2012 |
Tryptophan metabolites and brain disorders.
Topics: AIDS Dementia Complex; Brain Diseases; Central Nervous System Diseases; Humans; Huntington Disease; Kynurenine; Quinolinic Acid; Tryptophan | 2003 |
Integrative hypothesis for Huntington's disease: a brief review of experimental evidence.
Topics: Animals; Calcium; Cell Death; Disease Models, Animal; Energy Metabolism; Excitatory Amino Acids; Humans; Huntington Disease; Inflammation; Kynurenic Acid; Mice; Mice, Transgenic; Mutation; Neurons; Nitro Compounds; Oxidative Stress; Propionates; Quinolinic Acid; Serotonin Plasma Membrane Transport Proteins; Trinucleotide Repeats; Tryptophan | 2007 |
Neurochemical-clinical correlates in Huntington's disease--applications of brain banking techniques.
Topics: Brain Chemistry; Humans; Huntington Disease; Neurotransmitter Agents; Tissue Banks; Tryptophan | 1993 |
1 trial(s) available for tryptophan and Huntington Disease
| Article | Year |
|---|---|
Dietary enhancement of CNS neurotransmitters.
Topics: Acetylcholine; Administration, Oral; Brain; Choline; Clinical Trials as Topic; Diet; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine; Serotonin; Tryptophan | 1978 |
23 other study(ies) available for tryptophan and Huntington Disease
| Article | Year |
|---|---|
Assessing and Modulating Kynurenine Pathway Dynamics in Huntington's Disease: Focus on Kynurenine 3-Monooxygenase.
Topics: Aged; Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Huntingtin Protein; Huntington Disease; Kynurenine; Kynurenine 3-Monooxygenase; Male; Metabolic Networks and Pathways; Middle Aged; Neuroprotective Agents; Tryptophan | 2018 |
Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Topics: Aging; Animals; Brain; Cerebellum; Corpus Striatum; Female; Genotype; Huntington Disease; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Mice; Quinolinic Acid; Serotonin; Signal Transduction; Tryptophan; Tryptophan Oxygenase | 2013 |
Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.
Topics: Age Factors; Animals; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Female; Huntingtin Protein; Huntington Disease; Kynurenine; Metabolic Diseases; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; Time Factors; Tritium; Tryptophan | 2010 |
The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila melanogaster; Huntington Disease; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Nerve Degeneration; Neuroprotective Agents; Tryptophan; Tryptophan Oxygenase | 2011 |
Transgenic rat model of Huntington's disease.
Topics: Animals; Animals, Genetically Modified; Cell Nucleus; Disease Models, Animal; Disease Progression; DNA, Complementary; Glucose; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Magnetic Resonance Imaging; Models, Genetic; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phenotype; Promoter Regions, Genetic; Rats; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Transgenes; Trinucleotide Repeat Expansion; Tryptophan | 2003 |
Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
Topics: Adolescent; Adult; Aged; Aldehydes; Brain; Female; Humans; Huntington Disease; Kynurenine; Male; Malondialdehyde; Middle Aged; Neopterin; Nerve Growth Factors; Oxidative Stress; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tryptophan | 2005 |
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
Topics: Administration, Oral; Aged; Biomarkers; Brain; Brain Injury, Chronic; Down-Regulation; Female; Food, Formulated; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lipid Peroxidation; Male; Melatonin; Middle Aged; Neopterin; Oxidative Stress; Reference Values; Serotonin; Tryptophan; Up-Regulation | 2006 |
Structure of FBP11 WW1-PL ligand complex reveals the mechanism of proline-rich ligand recognition by group II/III WW domains.
Topics: Amino Acid Motifs; Carrier Proteins; Humans; Huntington Disease; Leucine; Ligands; Magnetic Resonance Spectroscopy; Peptides; Proline; Proline-Rich Protein Domains; Protein Structure, Tertiary; Rett Syndrome; Ribonucleoprotein, U1 Small Nuclear; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Tryptophan | 2006 |
Blood monoamine metabolism in Huntington's disease.
Topics: Adolescent; Adult; Aged; Blood Platelets; Central Nervous System; Dopamine; Epinephrine; Female; Humans; Huntington Disease; Male; Middle Aged; Monoamine Oxidase; Neurotransmitter Agents; Norepinephrine; Serotonin; Tryptophan | 1980 |
Huntington's disease and low tryptophan diet.
Topics: Brain; Female; Humans; Huntington Disease; Models, Biological; Nerve Degeneration; Quinolinic Acid; Tryptophan | 1993 |
Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease.
Topics: Adolescent; Adult; Female; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Male; Middle Aged; Tryptophan | 1995 |
Activated immune system in patients with Huntington's disease.
Topics: Adult; Antigens, CD; Complement C3; Female; Humans; Huntington Disease; Immunoglobulins; Kynurenine; Male; Middle Aged; Neopterin; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tryptophan | 1998 |
Degradation of tryptophan in neurodegenerative disorders.
Topics: Alzheimer Disease; Biomarkers; Humans; Huntington Disease; Intellectual Disability; Interleukin-2; Kynurenine; Neopterin; Receptors, Interleukin-2; Receptors, Tumor Necrosis Factor; Tryptophan; Tumor Necrosis Factor-alpha | 1999 |
Transmitters and related substances in brain material: an index of terminal and/or post-mortem biochemical change.
Topics: Brain; Carboxy-Lyases; Cauda Equina; Glutamate Decarboxylase; Humans; Huntington Disease; Neurotransmitter Agents; Nucleus Accumbens; Postmortem Changes; Schizophrenia; Tryptophan | 1978 |
Plasma glucose, non-esterified fatty acids and amino acids in Huntington's chorea.
Topics: Amino Acids; Blood Glucose; Fasting; Fatty Acids, Nonesterified; Glucose; Glucose Tolerance Test; Humans; Huntington Disease; Insulin; Serum Albumin; Tryptophan | 1977 |
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Energy Metabolism; Free Radicals; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Middle Aged; Parkinson Disease; Purines; Tryptophan; Tyrosine | 1992 |
Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.
Topics: Aged; Autopsy; Corpus Striatum; Female; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Male; Middle Aged; Putamen; Reference Values; Tryptophan; Tyrosine | 1990 |
Increased brain 3-hydroxykynurenine in Huntington's disease.
Topics: Brain Chemistry; Cerebral Cortex; Humans; Huntington Disease; Kynurenine; Tryptophan | 1989 |
[Tryptophan loading test in Huntington's chorea].
Topics: Adolescent; Adult; Amino Acids; Chromatography, Ion Exchange; Female; Humans; Huntington Disease; Male; Middle Aged; Tryptophan | 1969 |
Serum levels of phenylalanine and tyrosine in Huntington's chorea.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Body Weight; Dopamine; Female; Humans; Huntington Disease; Male; Middle Aged; Norepinephrine; Parasympatholytics; Phenylalanine; Psychotic Disorders; Reserpine; Schizophrenia; Tryptophan; Tyrosine | 1971 |
Huntington's chorea and tryptophan.
Topics: Extrapyramidal Tracts; Humans; Huntington Disease; Motor Skills; Pyridoxine; Serotonin; Tryptophan | 1972 |
Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea.
Topics: Acid Phosphatase; Adult; Aged; Amines; Amino Acids; Blood Proteins; Cerebrospinal Fluid Proteins; Dopamine; Female; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lysosomes; Male; Middle Aged; Phenylacetates; Serotonin; Sulfatases; Tryptophan; Tyrosine | 1973 |
Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans.
Topics: Amino Acids; Blood Proteins; Brain; Diet; Eating; Fasting; Feeding Behavior; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Parkinson Disease; Protein Binding; Tryptophan | 1974 |